Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Sivori

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
FEBS Letters|May 11, 2011
Human NK receptors: from the molecules to the therapy of high risk leukemiasLorenzo Moretta, Franco Locatelli, Daniela Pende, et al.
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Blood|February 12, 2010
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2Simona Sivori, Michela Falco, Simona Carlomagno, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Oncoimmunology|July 18, 2024
Human NK cells and cancerClaudia Cantoni, Michela Falco, Massimo Vitale, et al.
Frontiers in Immunology|April 27, 2019
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in HumansMonica Parodi, Herman Favoreel, Giovanni Candiano, et al.
Frontiers in Immunology|June 6, 2018
Late Development of FcεRγ<sup>neg</sup> Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation RecipientsLetizia Muccio, Michela Falco, Alice Bertaina, et al.
Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.
International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
FEBS Letters|May 11, 2011
Human NK receptors: from the molecules to the therapy of high risk leukemiasLorenzo Moretta, Franco Locatelli, Daniela Pende, et al.
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Blood|February 12, 2010
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2Simona Sivori, Michela Falco, Simona Carlomagno, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Oncoimmunology|July 18, 2024
Human NK cells and cancerClaudia Cantoni, Michela Falco, Massimo Vitale, et al.
Frontiers in Immunology|April 27, 2019
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in HumansMonica Parodi, Herman Favoreel, Giovanni Candiano, et al.
Frontiers in Immunology|June 6, 2018
Late Development of FcεRγ<sup>neg</sup> Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation RecipientsLetizia Muccio, Michela Falco, Alice Bertaina, et al.
Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.
International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Pageof 7